These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12125944)

  • 41. Alopecia areata. Pathogenesis and topical immunotherapy.
    Perret CM; Steijlen PM; Happle R
    Int J Dermatol; 1990 Mar; 29(2):83-8. PubMed ID: 2182554
    [No Abstract]   [Full Text] [Related]  

  • 42. Discoid lupus erythematosus exacerbated by contact dermatitis caused by use of squaric acid dibutylester for topical immunotherapy in a patient with alopecia areata.
    Shimaoka Y; Hatamochi A; Hamasaki Y; Suzuki H; Ikeda H; Yamazaki S
    J Dermatol; 2008 Mar; 35(3):151-3. PubMed ID: 18346258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Topical immunotherapy in alopecia areata.
    Happle R
    J Invest Dermatol; 1991 May; 96(5):71S-72S. PubMed ID: 2022878
    [No Abstract]   [Full Text] [Related]  

  • 44. Role of topical immunotherapy in the treatment of alopecia areata. Quality analysis of articles published between January 1977 and January 1988 about three treatments. Reading Group.
    Naldi L; Parazzini F; Cainelli T
    J Am Acad Dermatol; 1990 Apr; 22(4):654-6. PubMed ID: 2138637
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alopecia areata: topical immunotherapy--application and practical problems.
    MacDonald N; Wiseman MC; Shapiro J
    J Cutan Med Surg; 1999 Nov; 3 Suppl 3():S36-40. PubMed ID: 11776938
    [No Abstract]   [Full Text] [Related]  

  • 46. Diphenylcyclopropenone immunotherapy in ophiasis.
    Singh G; Okade R; Naik C; Dayanand CD
    Indian J Dermatol Venereol Leprol; 2007; 73(6):432-3. PubMed ID: 18032873
    [No Abstract]   [Full Text] [Related]  

  • 47. Topical immunotherapy of alopecia areata.
    van der Steen PH; Happle R
    Dermatol Clin; 1993 Jul; 11(3):619-22. PubMed ID: 8365044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Topical immunotherapy with contact allergens in alopecia areata: evidence for non-specific systemic suppression of cellular immune reactions.
    Bröcker EB; John SM; Steinhausen D; Hamm H
    Arch Dermatol Res; 1991; 283(2):133-4. PubMed ID: 2069412
    [No Abstract]   [Full Text] [Related]  

  • 49. Topical treatment of alopecia areata.
    Swanson NA; Mitchell AJ; Leahy MS; Headington JT; Diaz LA
    Arch Dermatol; 1981 Jul; 117(7):384-7. PubMed ID: 7259216
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Alopecia and immunotherapy using 2,4-dinitrochlorobenzene (author's transl)].
    Prenosil J
    Cesk Dermatol; 1981 Oct; 56(5):307-11. PubMed ID: 7307091
    [No Abstract]   [Full Text] [Related]  

  • 51. Effective squaric acid dibutylester immunotherapy is associated with a reduction of skin infiltrating T-helper (Th)1 and Th17 cells in alopecia areata patients.
    Avitabile S; Sordi D; Garcovich S; Colonna L; De Luca A; Nasorri F; Mazzanti C; Cavani A
    J Dermatol; 2015 Jan; 42(1):98-9. PubMed ID: 25495487
    [No Abstract]   [Full Text] [Related]  

  • 52. [Dinitrochlorobenzene in the therapy of alopecia areata. Our clinical experience].
    Tosti A; Veronesi S; Caponeri G
    G Ital Dermatol Venereol; 1984; 119(2):131-4. PubMed ID: 6735445
    [No Abstract]   [Full Text] [Related]  

  • 53. [DNCB therapy for alopecia areata (author's transl)].
    Zisiadis S; Wüthrich B; Schnyder UW
    Dermatologica; 1980; 161(6):365-71. PubMed ID: 7215615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of topical dinitrochlorobenzene.
    Stricker RB; Goldberg B
    Lancet; 1995 Nov; 346(8985):1293. PubMed ID: 7475731
    [No Abstract]   [Full Text] [Related]  

  • 55. Treatment of alopecia areata with dinitrochlorobenzene.
    Temmerman L; de Weert J; de Keyser L; Kint A
    Acta Derm Venereol; 1984; 64(5):441-3. PubMed ID: 6208729
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dinitrochlorobenzene therapy for alopecia areata.
    Happle R; Cebulla K; Echternacht-Happle K
    Arch Dermatol; 1978 Nov; 114(11):1629-31. PubMed ID: 152611
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Dinitrochlorobenzene treatment of alopecia areata].
    de Groot AC; Nater JP; de Jong MC
    Ned Tijdschr Geneeskd; 1980 Sep; 124(39):1634-40. PubMed ID: 7412951
    [No Abstract]   [Full Text] [Related]  

  • 58. Therapy of alopecia areata: on the cusp and in the future.
    Price VH
    J Investig Dermatol Symp Proc; 2003 Oct; 8(2):207-11. PubMed ID: 14582675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Topical immunotherapy for alopecia areata: re-evaluation of 139 cases after an additional follow-up period of 19 months.
    van der Steen PH; Boezeman JB; Happle R
    Dermatology; 1992; 184(3):198-201. PubMed ID: 1392112
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interventions for alopecia areata.
    Delamere FM; Sladden MM; Dobbins HM; Leonardi-Bee J
    Cochrane Database Syst Rev; 2008 Apr; (2):CD004413. PubMed ID: 18425901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.